Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 1;12(1):14912.
doi: 10.1038/s41598-022-19072-0.

Clinical and radiological evaluation of maxillofacial and otorhinolaryngological manifestations of Hansen's disease

Affiliations

Clinical and radiological evaluation of maxillofacial and otorhinolaryngological manifestations of Hansen's disease

Rachel Bertolani do Espírito Santo et al. Sci Rep. .

Abstract

To characterize maxillofacial, otorhinolaryngological and oral manifestations of Hansen's disease (HD), we conducted a cross-sectional study in 21 current patients attending the Unidade Básica de Saúde de Jardim América, Espírito Santo, Brazil and 16 former patients resident at Pedro Fontes Hospital using data from computed tomography imaging, rhinoscopy, and oroscopy. Maxillofacial characteristics were compared with 37 controls. Differences in bone alterations across the three groups were determined mainly by severe resorption/atrophy being more frequent in former HD patients, with severe resorption/atrophy of the anterior alveolar process of maxilla in 50.0% (8/16) of former patients, 28.6% (6/21) of current patients and 10.8% (4/37) of controls and of nasal bones and aperture in 31.3% (5/16) of former patients compared with 0/21 current patients and two controls. There were no substantial differences in otorhinolaryngological and oroscopic findings between the two patient groups. HD patients had more tooth loss than the age-matched control group. Maxillofacial, otorhinolaryngological and oroscopic finding scores were strongly correlated only in current HD patients. Correlation between otorhinolaryngological and maxillofacial scores suggests that protocols for HD patient assessment and follow-up could include otorhinolaryngological evaluation, with radiological imaging where necessary, subject to replication of our findings in a larger study.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Maxillofacial bone change score and otorhinolaryngological and oroscopic finding scores in controls and in current and former Hansen’s disease patients.
Figure 2
Figure 2
Correlation between otorhinolaryngological and oroscopic findings and maxillofacial bone alterations in current Hansen’s disease patients (see Table 4 for correlation coefficients).
Figure 3
Figure 3
Correlation between otorhinolaryngological and oroscopic findings and maxillofacial bone alterations in former Hansen’s disease patient (see Table 4 for correlation coefficients).
Figure 4
Figure 4
Correlation between maxillofacial bone alterations score and age in current and former Hansen’s disease patients and non-Hansen’s disease controls (see Table 4 for correlation coefficients).
Figure 5
Figure 5
Correlation between otorhinolaryngological score and age in current and former Hansen’s disease patients (see Table 4 for correlation coefficients).
Figure 6
Figure 6
Correlation between oroscopic score and age in current and former Hansen’s disease patients (see Table 4 for correlation coefficients).

Similar articles

Cited by

References

    1. Chen KH, Lin CY, Su SB, Chen KT. Leprosy: A review of epidemiology, clinical diagnosis, and management. J. Trop. Med. 2022;2022:8652062. doi: 10.1155/2022/8652062. - DOI - PMC - PubMed
    1. Cabral N, de Figueiredo V, Gandini M, de Souza CF, Medeiros RA, Lery LMS, Lara FA, de Macedo CS, Pessolani MCV, Pereira GMB. Modulation of the response to Mycobacterium leprae and pathogenesis of leprosy. Front. Microbiol. 2022;13:918009. doi: 10.3389/fmicb.2022.918009. - DOI - PMC - PubMed
    1. Froes LARJ, Sotto MN, Trindade MAB. Leprosy: Clinical and immunopathological characteristics. An. Bras. Dermatol. 2022;97(3):338–347. doi: 10.1016/j.abd.2021.08.006. - DOI - PMC - PubMed
    1. Towards Zero Leprosy. Global Leprosy (Hansen’s Disease) Strategy 2021–2030. https://www.who.int/publications/i/item/9789290228509.
    1. Souza CDF, Fernandes T, Matos TS, Tavares CM. Leprosy in the elderly population of an endemic state in the Brazilian Northeast (2001–2017): epidemiological scenario. An. Bras. Dermatol. 2020;95(1):91–94. doi: 10.1016/j.abd.2019.01.011. - DOI - PMC - PubMed